Acquisition - May 10, 2022
ZS acquires Danish Intomics
The global professional services firm ZS has acquired Danish bioinformatics and systems biology company, Intomics. Founded in Copenhagen, Denmark in 2008, Intomics accelerates and optimizes pharmaceutical drug discovery and development by enabling complex analysis of biomedical data. The addition of renowned scientists to the ZS team will strengthen ZS’s focus on the discovery of new […]
Acquisition - May 8, 2022
Prevas acquires BitSim NOW
Prevas has signed an agreement for the acquisition of 100 percent of BitSim NOW AB, a subsidiary of Vironova. BitSim NOW is a consulting firm in Stockholm with 35 employees focusing on innovative product development. Examples of areas of strength are digital cameras, image processing and vision technology as well as FPGA circuit development. Customers […]
Acquisition - April 20, 2022
Ilya Pharma makes strategic investment in bioanalytical company
Ilya Pharma has made a strategic investment in its supply chain to facilitate development of its ILP pipeline by acquiring one of its long-term partners, Nordic Bioanalysis. Founded in 2010, Nordic Bioanalysis have established a strong reputation both in the Nordics and internationally as experts in bioanalytical development and validation for pharmaceuticals, classic small molecules […]
Acquisition - April 4, 2022
AddLife acquires O’Flynn Medical and BioCat
AddLife acquires Irish company O’Flynn Medical and German company BioCat. O’Flynn Medical is an independent distributor offering product sales, rental and technical services to the hospital sector, private customers and nursing homes in Ireland. The company will become part of the Healthcare 21 Group, which AddLife acquired to the business area Medtech in 2021. O’Flynn […]
Acquisition - February 20, 2022
Recipharm acquires Arranta Bio and Vibalogics
Recipharm has announced the acquisition of Arranta Bio, an advanced therapy CDMO, and Vibalogics, a virotherapy CDMO and a portfolio company of Ampersand Capital Partners. The acquisition of Arranta Bio forms a cornerstone of Recipharm’s strategy to provide innovative drug developers in the biologics market with scientifically differentiated contract development and manufacturing services for ATMPs […]
Acquisition - February 18, 2022
Xbrane pauses negotiations with expected acquirer of Primm Pharma
Xbrane Biopharma’s efforts to divest the subsidiary Primm Pharma continues although negotiations with the previously expected acquirer NewFaDem for the time being has been paused. Primm Pharma is a fully owned subsidiary of Xbrane specialized in long-acting injectables and developer of Spherotide, a long-acting triptorelin formulation candidate intended to be used in treatment of prostate […]
